MIG Capital

⭐️ We're part of the European Innovation Council’s 𝗧𝗿𝘂𝘀𝘁𝗲𝗱 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗡𝗲𝘁𝘄𝗼𝗿𝗸! Proud to be a founding member of the European Commission’s Trusted Investors Network, joining 70+ leading investors with over €90 billion in assets dedicated to scaling Europe’s #deeptech sector. By signing the charter, we’re committed to co-investing with the EIC Fund to support Europe’s most disruptive #startups. 👏🏼 🇪🇺 We’re excited for the future and look forward to helping deep tech and innovative startups thrive on the global stage! European Innovation Council and SMEs Executive Agency (EISMEA), APEX Ventures, 360 Capital, Applied Ventures, Earlybird Venture Capital, Nordic Alpha Partners, UVC Partners, SPRIND - Bundesagentur für Sprunginnovationen, Tech Tour

What day is it again? Oh right, it's #FinanceDay! 💸   We had the opportunity to participate in the insightful pharma & biotech panel at #FinanceDayLeipzig, where industry leaders, including our very own Andreas Kastenbauer, shared their expertise alongside Andreas Schmidt (PhD.) (Springboard Health Angels), Dr. Manja Epping (Taylor Wessing Germany), and Joachim Vogt (AbbVie).   Key takeaways:   💡 Andreas emphasized the importance of aligning investors and founders on valuation and exit strategies. He also highlighted how rNPV shall guide founders in any kind of deal from out licensing to M&A. He pointed out the challenges in M&A, especially in balancing earn-outs with upfront payments and advised founders not to out license their lead products.    💼 Dr. Manja Epping spoke on the complexities of deal structuring with pharma, stressing the need for transparency early on and preparing for potential M&A scenarios. Every asset deal requires flexibility and careful handling of transitional solutions.   🔬 Joachim Vogt touched on the long-term nature of pharma partnerships, noting that trust and alignment on technology are key. Once the right foundation is set, exits can happen quickly when timing and chemistry align.   🤖 Andreas Schmidt (PhD.) discussed the paradigm shift in life sciences, driven by data science and globalization. He stressed the need for different mindsets and skill sets depending on geographic exit paths, and how collaboration is critical for startups’ growth.   A fantastic discussion on the future of #pharma and #biotech Plattform Life Sciences! 🧬

🇪🇺 Europe needs to raise the bar for startup investments! In his FOCUS online interview, Michael Motschmann emphasizes the immense potential in tech and biotech sectors. It's time to focus on #opportunities, not just risks, right? 🚀 Check out the full interview!

Wrapped up the MIG Capital VC Summit 2024 in the best way possible: hiking up the Hahnenkamm and enjoying a summit breakfast with the whole crew at Restaurant Hochkitzbühel 🏞️🍳 It was the perfect way to reflect on all the insights, connections, and shared experiences from the past few days. 🔑 Final thoughts: •⁠ ⁠The VC landscape is constantly evolving, and staying ahead means adapting fast. •⁠ ⁠Building strong relationships is just as important as finding great startups. •⁠ ⁠Sometimes, the best ideas come when you step outside the conference room and into the fresh mountain air. Until next time, Kitzbühel! 🦌

Day 2 at the VC Summit didn’t disappoint! 🦌 From thought-provoking panels to next-gen startup pitches, the energy was 🔥 all around. The day was packed with discussions on some of the most crucial topics in #venturecapital:   • Data as key milestones in the growth of our portfolio companies, with a deep dive into its importance for our #LifeSciences investments such as iOmx Therapeutics AG and NeraCare • Progress updates from our portfolio companies since the last summit  • Technology sovereignty in Europe with Soren Hein, Oliver Kahl, Christina Vogt-Sasse, and Dr. Stefan Seegerer from IQM Quantum Computers • MIG Capital’s investment strategy for the future   💬 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 – we had great opportunities to connect with both brilliant #founders and forward-thinking #investors, sparking many exciting conversations. 𝗢𝘂𝗿 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆: The magic truly happens in the conversations between the presentations.   Now, we’re all geared up for tomorrow’s hike and summit breakfast on the Hahnenkamm! 🏔️ 👏🏼 Apollon Papadimitriou, Daniel von Janowski, Yves Kremer, Johannes B. Woehrstein, Harpreet Singh, Claus Schalper, Jan Poth, Rosmarie W., Marco Hässler, Jörg Umlauft, Michael Motschmann

What a kickoff in #Kitzbühel! 🦌 Today’s workshops at the MIG Capital VC Summit were packed with insights and inspiration. 💡 One highlight was Christina Vogt-Sasse's and Oliver Kahl’s session, “KI in aller Munde” (“AI is Everywhere”), where we explored the pivotal role of #AI in our portfolio companies. We heard great examples of how AI has become the backbone of some of the most innovative products we back, because AI isn’t just an add-on — it’s a game-changer: 🧪 Johannes B. Woehrstein shared how mbiomics GmbH relies on AI to analyze massive datasets from diverse bacterial cultures. 🐕 Oliver W. Huber explained how HawkCell uses AI to filter noise from MRI images, pushing the boundaries of medical imaging. 🪨 Sebastian-Friedrich Kowitz showed us how talpasolutions integrates AI at its core to automatically detect anomalies from sensor data, revolutionizing the mining industry. Tomorrow: Big conference day + some serious networking! 🚀

🚀 #FinanceDayLeipzig – Jetzt anmelden! 🚀 Freuen Sie sich am 24. Oktober auf das Panel "#Pharma und #Biotech: Von #Kollaboration bis #M&A" mit Top-Experten aus der Branche: • Andreas Schmidt (PhD.) Managing Director Springboard Health Angels & SVP, Singleron Biotechnologies • Dr. Manja Epping, Partnerin, Taylor Wessing Germany • Joachim Vogt, Director, Search and Evaluation International, AbbVie • Andreas Kastenbauer, Partner, MIG Capital Moderation: Uli Kinzel, Partner, Bryan, Garnier & Co 💡 Sie erhalten wertvolle Einblicke in die neuesten Trends und Strategien. 🔗 Sichern Sie sich noch heute Ihr Ticket für den #FinanceDay Leipzig! https://lnkd.in/eAxP7WBv biosaxony Leipzig for LifeChangers HTGF | High-Tech Gründerfonds Netzwerker BIODeutschland CFGI Germany WTS Advisory bm-t beteiligungsmanagement thüringen GmbH MC Services AG FCF Fox Corporate Finance GmbH

Hypros, formerly GWA Hygiene GmbH, has taken a significant step forward with two new investors on board: Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern mbH and ESB Invest Vorpommern GmbH. 👏🏼 This partnership enhances Hypros' commitment to advancing digital healthcare through innovative #IoT solutions for hospital efficiency and patient safety. With these investments, Hypros is poised to accelerate its platform development and meet the rising demand for digital transformation in #healthcare. 🧬 Thank you to Tobias K. Gebhardt, Max Golubew, and their teams for their dedication. 💪🏼

Excited that I will be speaking at Frontiers Health, in Berlin on October 17-18. Looking forward to meeting all of you 🎉 #FH24 #lifesciences #healthequity #digitalhealth #biomedicalinnovation #patientcare #healthcare #migcapital

By year’s end, #Alzheimer’s treatment might enter a new era — here’s why: A recent article on SWI swissinfo.ch sheds light on the exciting progress in Alzheimer's research, featuring insights from Andrea Pfeifer, CEO of AC Immune. 👩🏻🔬 Swissmedic is expected to decide by the end of the year on approving a groundbreaking new drug. 🧬 Worth a read for anyone following the latest in life sciences and biotech! Link to the article in the comments. 👇🏼